HT
JAZZ icon

HAP Trading’s Jazz Pharmaceuticals JAZZ Stock Holding History

HAP Trading’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-30,199
Closed -$4.31M – 2335
2020
Q3 		$4.31M Buy
30,199
+15,565
+106% +$1.93M 0.21% 83
2020
Q2 		$1.61M Buy
+14,634
New +$1.62M 0.09% 199

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

HAP Trading's JAZZ Position: Q4 2020 in Review

HAP Trading sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2020, closing a stake of 30,199 shares — an estimated $4.31M sold.

HAP Trading first reported a position in JAZZ in Q2 2020 and held it in 2 quarters. The position peaked at $4.31M in Q3 2020. 437 funds tracked by Wall St. Rank hold JAZZ as of Q4 2020.

  • HAP Trading reported no remaining Jazz Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • HAP Trading sold 30,199 Jazz Pharmaceuticals shares in Q4 2020, an estimated $4.31M.
  • HAP Trading first reported a position in Jazz Pharmaceuticals in Q2 2020 and held it in 2 quarters.
  • HAP Trading's Jazz Pharmaceuticals position peaked at $4.31M in Q3 2020.
  • 437 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2020.

Based on HAP Trading's 13F filing for Q4 2020, filed 16 Feb 2021.